AT446377T

Method of diagnosis for recognition of carriers of the Marburg I variant of factor VII activating protease (FSAP) by differential modulation of FSAP activity

Abstract

Diagnostic procedure for detection of people who have a heterozygous expression or genetically conditioned homozygous MR I variant protease that activates factor VII (FSAP), in which the activity of FSAP is determined, wherein the activity is determined the FSAP is contained in a sample, in the absence and in the presence of a differential activity modulator, in which the differential activity modulator changes the activity of FSAP in samples of people who have a heterozygous expression or genetically homozygous conditioned MR I variant of FSAP in an amplitude that is different from the amplitude samples of people who do not express the MRI FSAP variant.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

13 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims2

Priority claims
DocumentOfficeKindDate
102005062053GermanyA
102005062055GermanyA

Members13

Family members, oldest first
DocumentOfficeKind
CA2571660A1CanadaA1
EP1801233A1European Patent Office (EPO)A1
DE102005062053A1GermanyA1
DE102005062055A1GermanyA1
JP2007167069AJapanA
US2007190574A1United States of AmericaA1
EP1801233B1European Patent Office (EPO)B1
AT446377TThis recordAustriaT
ATE446377T1AustriaT1
DE502006005169D1GermanyD1
ES2332467T3SpainT3
US7943333B2United States of AmericaB2
JP4991273B2JapanB2